3.0CHF
118.02 MCHF
636.18 MCHF
About BIOTEST
Sector
CEO
Peter Janssen
Headquarters
Dreieich
Website
Employees (FY)
2.43 K
Founded
1946
ISIN
DE0005227235
FIGI
BBG006TLNDD0
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs. It operates through the following segments: Therapy, Plasma and Services, and Other. The Therapy segment develops and produces blood plasma-based immunoglobulins, clotting factors, and albumins which are used to treat diseases of the immune system, haematological diseases, and in intensive care medicine. The Plasma and Services segment includes the areas of plasma sales and contract manufacturing. The Other segment refers to the merchandise business. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIO3 is 24.4 CHF — it has increased by 0.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange BIOTEST stocks are traded under the ticker BIO3.
BIOTEST is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BIO3 stock is 0.21% volatile and has beta coefficient of 0.02. Check out the list of the most volatile stocks — is BIOTEST there?
Yes, you can track BIOTEST financials in yearly and quarterly reports right on TradingView.
BIO3 net income for the last quarter is 35.87 M CHF, while the quarter before that showed 83.81 M CHF of net income which accounts for −57.20% change. Track more BIOTEST financial stats to get the full picture.
Today BIOTEST has the market capitalization of 1.11 B, it has decreased by 1.27% over the last week.
Like other stocks, BIO3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTEST stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.43 K employees. See our rating of the largest employees — is BIOTEST on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOTEST technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOTEST stock shows the neutral signal. See more of BIOTEST technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.